Collection of Blood From Patients With Prostate Cancer
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Phase II Sunitinib Prog Met AIPC
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CMAB vs IMAB in Metastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE4
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
- Status
- TERMINATED
- Phase
- PHASE3
PROSTACOX : Metastatic Prostate Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2